A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women

Clinical trial NCT01953809 · WITHDRAWN

Trial details

NCT number: NCT01953809
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Infections, Bacterial

Start date: 2014-08-01
Primary completion: 2015-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.